Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinoma.

Miller, A A

Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinoma. [electronic resource] - Cancer Aug 1996 - 789-93 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0008-543X

10.1002/(SICI)1097-0142(19960815)78:4<789::AID-CNCR15>3.0.CO;2-R doi


Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal--adverse effects
Aromatase Inhibitors
Breast Neoplasms--blood
Dose-Response Relationship, Drug
Estrogen Antagonists--adverse effects
Fadrozole--adverse effects
Female
Humans
Middle Aged
Neoplasm Metastasis
Neoplasms, Hormone-Dependent--blood
Postmenopause
Prospective Studies